US Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

Wednesday, February 12, 2020 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Feb. 11, 2020 /PRNewswire/ --

US Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

Read the full report: https://www.reportlinker.com/p05825743/?utm_source=PRN

This new report contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including:  -Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years.  -Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.  -Test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals.  -Current instrumentation technologies and feature comparison of leading analyzers.  -Sales and market shares of  leading suppliers.  -Emerging diagnostic technologies and their potential market applications.  -Product development opportunities.  -Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies.  -Business opportunities and strategic recommendations for suppliers.Contains 567 pages and 50 tables Companies Profiled Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Fujirebio - Grifols - GSK Biologicals - Hologic - Leica Biosystems - Lonza - Ortho-Clinical Diagnostics - PerkinElmer - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens Healthineers - Takara Bio - Thermo Fisher - WakoRead the full report: https://www.reportlinker.com/p05825743/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/us-hospital-cancer-diagnostics-market-forecasts-for-major-tumor-markers-supplier-shares-by-test-competitive-landscape-innovative-technologies-instrumentation-review-301002699.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store